Your shopping cart is currently empty

XL44, as an hRpn13 binder, triggers hRpn13-dependent apoptosis and limits cell viability via a PCLAF-dependent mechanism. It causes ubiquitin-dependent degradation of hRpn13 Pru and ubiquitin-independent degradation of specific KEN box-containing proteins [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | XL44, as an hRpn13 binder, triggers hRpn13-dependent apoptosis and limits cell viability via a PCLAF-dependent mechanism. It causes ubiquitin-dependent degradation of hRpn13 Pru and ubiquitin-independent degradation of specific KEN box-containing proteins [1]. |
| In vitro | XL44, when applied at a concentration of 20 μM to RPMI 8226 cell lysates over a period of 4-24 hours, triggers apoptosis through an hRpn13-dependent mechanism and diminishes hRpn13Pru levels [1]. Western Blot Analysis confirms these findings [1]. |
| Molecular Weight | 388.39 |
| Formula | C23H17FN2O3 |
| Cas No. | 2637949-91-6 |
| Smiles | C(=C1C=2C(NC1=O)=CC=C(F)C2)C3=CC(NC(=O)C4=CC=C(OC)C=C4)=CC=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.